amrinone has been researched along with Cardiac Complex, Premature in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse effects are minimal, with dosage limited predominantly by decreases in filling pressures." | 2.37 | Intravenous use of amrinone for the treatment of the failing heart. ( LeJemtel, T; Mancini, D; Sonnenblick, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mancini, D | 1 |
| LeJemtel, T | 1 |
| Sonnenblick, E | 1 |
1 review available for amrinone and Cardiac Complex, Premature
| Article | Year |
|---|---|
Intravenous use of amrinone for the treatment of the failing heart.
Topics: Aminopyridines; Amrinone; Cardiac Complexes, Premature; Cardiac Output; Cardiotonic Agents; Drug Int | 1985 |